Lack of superiority of rivaroxaban for secondary prevention of embolic stroke of undetermined source
1. At a median follow-up of eleven months, rivaroxaban was not superior to aspirin for prevention of secondary stroke after ...
Tag: rivaroxaban
Aspirin comparable to rivaroxaban for extended venous thromboembolism prophylaxis following arthroplasty: The EPCAT II trial
1. Patients initially treated with rivaroxaban following total knee or hip arthroplasty experienced similar rates of venous thromboembolism (VTE) regardless ...
Extended rivaroxaban superior to aspirin in lowering risk of recurrent venous thromboembolism: The EINSTEIN CHOICE trial
1. The EINSTEIN CHOICE trial involved patients who had a history of venous thromboembolism (VTE) and had completed 6 to ...
Triple therapy with rivaroxaban reduces bleeding compared to warfarin: The PIONEER AF-PCI trial
1. In patients with atrial fibrillation (AF) who undergo percutaneous coronary intervention (PCI), treatment with rivaroxaban, in addition to dual ...
Rivaroxaban associated with increased bleeding risk compared with dabigatran in nonvalvular atrial fibrillation
1. Based on a retrospective cohort study of US Medicare patients, rivaroxaban was associated with a significantly increased risk of ...
The EINSTEIN-PE trial: Rivaroxaban to treat pulmonary embolism [Classics Series]
Image: PD 1. Rivaroxaban, an oral factor Xa inhibitor, was non-inferior to standard anticoagulation therapy (i.e. low-molecular weight heparin and ...
The EINSTEIN-DVT trial: Rivaroxaban in acute deep-vein thrombosis [Classics Series]
Image: PD 1. Rivaroxaban is non-inferior to standard therapy of enoxaparin and vitamin K antagonist in treating acute, symptomatic deep-vein ...
Rivaroxaban has no net clinical benefit over enoxaparin for thromboprophylaxis in acutely ill patients
Feb 6th - NEJM - Extended-duration rivaroxaban was superior to standard-duration enoxaparin for thromboprophylaxis, but was associated with increased bleeding ...
The ROCKET AF: Rivaroxaban in atrial fibrillation [Classics Series]
1. Rivaroxaban is non-inferior to warfarin in preventing strokes and systemic embolism. 2. Although there is no significant difference between ...
